Guaranteed Income to Boost HIV Care Continuity and Suppression Post-Jail Release (GI-BOOST)
Status
Conditions
Treatments
Study type
Funder types
Identifiers
Details and patient eligibility
About
The goal of this clinical trial is to understand the implementation requirements and potential health impacts of a guaranteed income (GI) intervention targeting people living with HIV with criminal legal involvement (PWH-CLI). The main questions it aims to answer are:
- How acceptable is a GI intervention, and its intervention components, among PWH-CLI participants and stakeholders?
- How feasible is a GI intervention for PWH-CLI? What are the implementation barriers and opportunities for this intervention?
- What is the preliminary efficacy of the GI intervention on improving HIV care outcomes for PWH-CLI? Researches will compare study engagement and study outcomes across three randomization arms (A: receive full GI amount as one lump sum payment; B: receive full GI amount split over nine monthly installments; C: participant chooses whether to receive GI as lump sum payment or monthly installments). HIV care outcomes will be compared against a retrospective cohort of PWH-CLI patients as historical controls.
Participants will:
- Be randomized to receive GI intervention as a lump sum payment or monthly installment (over nine months) or choose their preference.
- Complete 3 surveys throughout study follow up to assess experience with the intervention, experience with social services and benefits programs, experience with the criminal legal system, and HIV care outcomes.
- Be interviewed by the research team to further understand the experience with the intervention.
Full description
One-in-seven people living with HIV (PWH) experience incarceration annually. HIV prevalence among those with criminal legal involvement (CLI) is 3x higher than the general population. Upon release, PWH-CLI encounter competing priorities and structural barriers to addressing unmet basic needs, resulting in suboptimal care cascade outcomes. Guaranteed income (GI) through unconditional cash transfers can improve mental health, meet basic needs, and boost employment prospects. However, its effects on PWH-CLI, who face unique post-release challenges affecting HIV treatment retention and viral suppression, remain uncharacterized.
Our three-arm pilot study will assess the feasibility, acceptability, implementation requirements, and preliminary efficacy of a GI intervention to improve HIV care in PWH-CLI released from the San Francisco County (SFC) jail. We will randomize up to 39 very low-income patients discharged to a SFDPH network HIV clinic to 1 of 3 arms: A) one lump-sum payment of $6,750; B) 9-monthly installments of $750; or C) "preference" (patient chooses either A or B). We will offer opt-in financial mentoring (FM) sessions during the pilot to bolster GI impacts. Clinical appointment and viral load outcome data will be collected from medical records. All patients will complete quantitative surveys (1 baseline, 2 follow-up) to assess GI experience, patient context, and acceptability. Baseline and endline qualitative interviews with patients (n=12; 4/arm) will explore the GI experience, impacts on HIV treatment, and critical implementation questions to inform future research and policy. Qualitative interviews with system partners (n=10) will explore community perceptions of GI and opportunities to integrate GI in HIV programming and policy.
Given PWH-CLI's economic and social marginalization, we will leverage our existing retrospective cohort of PWH-CLI released from SFC jail as historical controls to test preliminary efficacy against pilot participants - comparing clinical appointments and viral load - instead of utilizing a concurrent no-GI control group. Variation in GI disbursement will provide needed data on acceptability and preliminary efficacy of distribution modes and the role of patient agency in pilot outcomes and overall engagement.
We will pilot a GI intervention for PWH-CLI leaving SFC jail, aiming to reduce structural barriers to care and improve HIV care cascade engagement. Our specific aims are to:
(Aim 1) Determine GI intervention acceptability among PWH-CLI and stakeholders. We will explore patient preference for GI disbursement and if GI mode impacts successful HIV care engagement and study procedures through longitudinal qualitative interviews. Thematic analysis will elucidate individual impacts of GI amidst contextual facilitators and barriers to care. Qualitative interviews with system partners will gauge community and policy perceptions of GI intervention acceptability and optimal means to integrate.
(Aim 2) Assess GI intervention feasibility and implementation barriers/opportunities for PWH-CLI. Feasibility measures include differences in study engagement (FM uptake, surveys) by randomization arm. We will assess reported GI receipt experience for PWH-CLI who do/not access other safety net programs and for those experiencing unstable housing, residential treatment programs, and re-incarceration to understand overlap and benefit combinations with other state/county programs to optimize future implementation.
(Aim 3) Test preliminary efficacy of the GI intervention on improving HIV care outcomes. By randomization arm, we will compare the percentage linked to an HIV care provider within 30 days of jail release, retained in HIV care (>= 2 visit >=90 days apart), and virally suppressed at 9 months. GI pilot HIV cascade outcomes will be compared to propensity-matched historical controls from our retrospective cohort of PWH-CLI. We will also assess group differences in re-incarceration rates.
A significant subset of PWH, PWH-CLI are among the least retained in HIV care and adherent to ART. This research will bridge current knowledge gaps by testing GI implementation strategies, assessing community support and integration opportunities, and testing preliminary efficacy in HIV care outcomes to inform a large-scale trial.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Participants will be eligible for this pilot study if they are 18 years of age or older, are living with an HIV diagnosis, have a recent incarceration in the San Francisco County Jail (within three months of study enrollment), and qualify as very low income (for example, currently experiencing homelessness or having an income less than 30% of the area median income). Participants must be English literate.
Exclusion criteria
- Individuals with an active psychosis who are not on treatment will be ineligible to enroll in the study (however, individuals with a psychiatric co-morbidity who are on treatment will remain eligible). For the purpose of the Focus Care enrollment (the method of GI disbursement), individuals who do not have a social security number or individual tax ID number will be ineligible for this pilot study.
Trial design
Primary purpose
Allocation
Interventional model
Masking
33 participants in 3 patient groups
Trial contacts and locations
Loading...
Central trial contact
Graham Hinchcliffe, MS; Paul D Wesson, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal